Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
Tamat
S R
SR
Department of Pharmacy, University of Sydney, Australia.
Patwardhan
A
A
Moore
D E
DE
Kabral
A
A
Bradstock
K
K
Hersey
P
P
Allen
B J
BJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001896:Boron Compounds / Q000276:immunology*; D004337:Drug Carriers; D006801:Humans; D007554:Isotopes; D007942:Leukemia, Experimental / Q000532:radiotherapy*; D008546:Melanoma, Experimental / Q000532:radiotherapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009502:Neutrons; D011882:Radiotherapy, High-Energy / Q000379:methods*
D000911:Antibodies, Monoclonal; D001896:Boron Compounds; D004337:Drug Carriers; D007554:Isotopes